Immunogenic
proteins from nonliving promastigote polyvalent
Leishmania vaccine against American tegumentary
leishmaniasis (Leishvacin ), produced by
Biobr s (Biochemistry of Brazil ), Montes Claros, State of Minas Gerais, Brazil, were identified and purified by
polyacrylamide electrophoresis gel and electroelution. C57BL/10 mice were vaccinated with
proteins with estimated molecular weights of 42, 46, 63, 66, 73, 87, 97, and 160kDa in three doses of 30 g of each
protein at 15-day intervals combined with 250 microg of Corynebacterium parvum followed by a challenge
infection with 10(5) infective promastigotes from Leishmania (Leishmania) amazonensis. The ability of these
proteins to induce immune response and protection was analyzed. No statistical difference was observed in the level of IFN-gamma induced by
proteins in vaccinated groups in comparison with control groups. Six months after challenge
infection, protection levels of 28.57; 42.86; 57.14; 42.86; 42.86, 57.14; 42.86 and 57.14% were demonstrated for each purified
protein.